As expected, the increased intracellular production of TNF-α is observed in patients in clusters I and III (Supplementary Figure 4C, middle panel) and more significantly in patients with fatal outcomes compared to surviving patients with severe COVID-19 in cluster I (Supplementary Figure 3C, right panel). This evidence concerns the gene TNF and COVID-19.